Product Images Tamsulosin Hydrochloride
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 7 images provide visual information about the product associated with Tamsulosin Hydrochloride NDC 50090-5553 by A-s Medication Solutions, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Label Image - lbl500905553
Figure 1 Mean Plasma Tamsulosin Hydrochloride Concentrations Following Single-Dose Administration of Tamsulosin Hydrochloride Capsules 0.4 mg Under Fasted and Fed Conditions (n=8) - tamsulosin fig1
Figure 2A Mean Change from Baseline in Total AUA Symptom Score (0 to 35) Study 1 - tamsulosin fig2
The text relates to a figure (Figure 2A) showing the mean change from baseline in the Total AUA Symptom Score (ranging from 0 to 35) for Study 1. The figure includes two treatment groups: one group received -OO-0-08mg_A and another group received A -A04my_O30 placebo. The duration of treatment (in weeks) is also shown on the figure.*
Figure 2B Mean Change from Baseline in Total AUA Symptom Score (0 to 35) Study 2 - tamsulosin fig3
The text describes a figure (2B) showing the mean change from baseline in a Total AUA Symptom Score on a scale from 0 to 35 for three treatments: O=0O—0-08mg LNt, 0.4mg, and placebo. The duration of treatment was measured in weeks, and the figure shows data points at weeks 0, 1, 2, 5, 9, 13, and LOCF.*
Figure 3A Mean Increase in Peak Urine Flow Rate (mL/Sec) Study 1 - tamsulosin fig4
This is a presentation of the mean increase in peak urine flow rate in mL/sec of Study 1. There are three categories of treatment represented in the graph as 0.08mg, 2x0.4mg, and Placebo. The duration of the treatment in weeks is shown on the bottom x-axis. The top x-axis shows the logarithmic scale of weeks. The y-axis denotes the mean change in urine flow rate in mL/sec. The sample sizes (n) are also given for each treatment category.*
Figure 3B Mean Increase in Peak Urine Flow Rate (mL/Sec) Study 2 - tamsulosin fig5
The text is describing a figure titled "Mean Increase in Peak Urine Flow Rate (mL/Sec) Study 2" displaying treatment and duration of treatment (in weeks) on the x-axis and the mean increase in peak urine flow rate (in mL/Sec) on the y-axis. It is not possible to determine the exact values without a visual representation of the figure.*
Chemical Structure - tamsulosin str
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.